These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5079088)

  • 41. Thermal inactivation of Semliki Forest virus.
    Fleming P
    J Gen Virol; 1971 Dec; 13(3):385-91. PubMed ID: 5168570
    [No Abstract]   [Full Text] [Related]  

  • 42. Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever.
    Sun Y; Tian DY; Li S; Meng QL; Zhao BB; Li Y; Li D; Ling LJ; Liao YJ; Qiu HJ
    Vaccine; 2013 Jan; 31(3):538-44. PubMed ID: 23153441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of Semliki Forest virus RNA replication: a model for the control of alphavirus pathogenesis in invertebrate hosts.
    Kim KH; Rümenapf T; Strauss EG; Strauss JH
    Virology; 2004 May; 323(1):153-63. PubMed ID: 15165827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The molecular pathogenesis of Semliki Forest virus: a model virus made useful?
    Atkins GJ; Sheahan BJ; Liljeström P
    J Gen Virol; 1999 Sep; 80 ( Pt 9)():2287-2297. PubMed ID: 10501479
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of extraneural arbovirus infection in the pathogenesis of encephalitis. An electron microscopic study of Semliki Forest virus infection in mice.
    Murphy FA; Harrison AK; Collin WK
    Lab Invest; 1970 Apr; 22(4):318-28. PubMed ID: 5429532
    [No Abstract]   [Full Text] [Related]  

  • 46. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.
    Cabrera A; Sáez D; Céspedes S; Andrews E; Oñate A
    Immunobiology; 2009; 214(6):467-74. PubMed ID: 19150742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
    Balcarova J; Helenius A; Simons K
    J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Semliki Forest virus inactivation. Selective destruction of the haemagglutinating activity by caseinase C and of infectivity by sodium deoxycholate.
    Osterrieth PM
    Life Sci; 1965 Jun; 4(12):1227-31. PubMed ID: 5840101
    [No Abstract]   [Full Text] [Related]  

  • 50. Virus spike protein complexes and virosomes as effective subunit vaccines.
    Morein B; Helenius A; Simons K; Schirrmacher V
    Adv Exp Med Biol; 1979; 114():811-6. PubMed ID: 313692
    [No Abstract]   [Full Text] [Related]  

  • 51. Cytopathic effect of Semliki Forest virus in the mosquito Aedes aegypti.
    Mims CA; Day MF; Marshall ID
    Am J Trop Med Hyg; 1966 Sep; 15(5):775-84. PubMed ID: 5917634
    [No Abstract]   [Full Text] [Related]  

  • 52. Difference in interferon response and protection from ocular virus infection in rabbits and monkeys.
    Kaufman HE; Ellison ED; Centifanto YM
    Am J Ophthalmol; 1972 Jul; 74(1):89-92. PubMed ID: 4338613
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute oral toxicity of methylrosaniline chloride.
    Hodge HC; Indra J; Drobeck HP; Duprey LP; Tainter ML
    Toxicol Appl Pharmacol; 1972 May; 22(1):1-5. PubMed ID: 5034986
    [No Abstract]   [Full Text] [Related]  

  • 54. Adsorptive endocytosis of Semliki Forest virus.
    Marsh M; Helenius A
    J Mol Biol; 1980 Sep; 142(3):439-54. PubMed ID: 7463480
    [No Abstract]   [Full Text] [Related]  

  • 55. Does a barbiturate drug given in lethal dose enter the cornea?
    Basu PK; Kapur BM; Ahad A
    Can J Ophthalmol; 1979 Jul; 14(3):181-5. PubMed ID: 487255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Preparation of glycerin solutions for intravenous administration. III. The pharmacodynamic properties of a glycerin solution].
    Sotnikov VS; Utkin DV; Obodan LZ; Smirnov VV
    Farm Zh; 1977; (6):56-61. PubMed ID: 598477
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of Semliki Forest virus on rabbit myxoma.
    GINDER DR; FRIEDEWALD WF
    Proc Soc Exp Biol Med; 1952 Apr; 79(4):615-8. PubMed ID: 14920513
    [No Abstract]   [Full Text] [Related]  

  • 58. [STUDY OF THE BIOLOGICAL NATURE OF THE VIRULENT PROPERTIES OF MICROBES. II. CHARACTER OF PNEUMOCOCCAL INFECTION IN WHITE MICE IN RELATION OF THE PATHWAY OF INFECTION AND THE DOSE OF THE PATHOGEN].
    ANATOLII SA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Feb; 42():120-4. PubMed ID: 14270019
    [No Abstract]   [Full Text] [Related]  

  • 59. Failure of dimethylsulfoxide to enhance experimental viral infection in laboratory animals.
    Chan JC; Ullal I; Valand RS; Gadebusch HH
    Z Naturforsch B; 1969 Jan; 24(1):145-6. PubMed ID: 4388869
    [No Abstract]   [Full Text] [Related]  

  • 60. Identifying the Role of E2 Domains on Alphavirus Neutralization and Protective Immune Responses.
    Weger-Lucarelli J; Aliota MT; Kamlangdee A; Osorio JE
    PLoS Negl Trop Dis; 2015; 9(10):e0004163. PubMed ID: 26473963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.